Elcelyx Therapeutics
San Diego, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
RE
Ralph E. ChristoffersonDirector
RJ
Richard J. BarryDirector
LT
Liang TsuiDirector
MR
Martin R. BrownExecutive Officer
AD
Alain D. BaronExecutive Officer, Director
GG
Ginger GrahamDirector
MF
Mark FinemanExecutive Officer
JG
Jim GlasheenDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$476.5KraisedNov 2018 · 2 investors · BiotechnologyRule 506(b)
▶$476.5KraisedNov 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ginger GrahamDirector
- Jim GlasheenDirector
- Mark FinemanExecutive Officer
- Christoffersen RalphDirector
- Richard BarryDirector
- Sandy MahatmeDirector
- Bosun HauDirector
- Alain BaronExecutive Officer, Director
- Liang TsuiDirector
- Jay SherwoodExecutive Officer
- Offering amount
- $1M
- Amount sold
- $476.5K
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20.1MraisedOct 2015 · 13 investors · BiotechnologyRule 506(b)
▶$20.1MraisedOct 2015 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ralph E. ChristoffersonDirector
- Richard J. BarryDirector
- Liang TsuiDirector
- Martin R. BrownExecutive Officer
- Alain D. BaronExecutive Officer, Director
- Ginger GrahamDirector
- Mark FinemanExecutive Officer
- Jim GlasheenDirector
- Offering amount
- $40.2M
- Amount sold
- $20.1M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.8MraisedFeb 2015 · 8 investors · BiotechnologyRule 506(b)
▶$5.8MraisedFeb 2015 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark FinemanExecutive Officer
- Jim GlasheenDirector
- Richard J. BarryDirector
- Brook ByersDirector
- Ginger GrahamDirector
- Martin R. BrownExecutive Officer
- Ralph E. ChristoffersonDirector
- Mark WigginsExecutive Officer
- Alain D. BaronExecutive Officer, Director
- Offering amount
- $9M
- Amount sold
- $5.8M
- Proceeds to insiders
- $1.3M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.